<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T20:45:53+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Alnylam第4款RNAi疗法III期研究成功</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/7c6HEwK1xK4jTni7ybRwlQ</id>
    <link href="https://mp.weixin.qq.com/s/7c6HEwK1xK4jTni7ybRwlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华东理工大学1.5亿元转让DHODH抑制剂相关专利</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/GaTaXmkU1ZIwkyp6mircDQ</id>
    <link href="https://mp.weixin.qq.com/s/GaTaXmkU1ZIwkyp6mircDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T药物未通过FDA生产核查，新基股东兑现期权遇阻</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/1eq6auUoI-gqPBM3FoHzvg</id>
    <link href="https://mp.weixin.qq.com/s/1eq6auUoI-gqPBM3FoHzvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床急需新药「布罗舒单抗」即将获批上市</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/ImzG98pa4CuWsW6qyp443g</id>
    <link href="https://mp.weixin.qq.com/s/ImzG98pa4CuWsW6qyp443g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>3款新药拟纳入优先审评，恒瑞、思路迪、苏庇医药</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/QygqyNHTvNOD0rXeOhopDg</id>
    <link href="https://mp.weixin.qq.com/s/QygqyNHTvNOD0rXeOhopDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞PD-L1/TGFβ双抗SHR-1701治疗晚期或转移性NSCLC适应症II期临床申请获得批准</title>
    <updated>2021-01-08T18:14:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/bm8SwL3TIeTjiB3yIOAR7Q</id>
    <link href="https://mp.weixin.qq.com/s/bm8SwL3TIeTjiB3yIOAR7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田1类新药「美阿沙坦钾片」即将获批上市</title>
    <updated>2021-01-07T17:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/jMcHSqhhekLPDsWDKvZ53A</id>
    <link href="https://mp.weixin.qq.com/s/jMcHSqhhekLPDsWDKvZ53A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>改良型新药！齐鲁制药「奥氮平口溶膜」即将获批上市</title>
    <updated>2021-01-07T17:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/5__o5R5SCcQf_tYFyGxEXg</id>
    <link href="https://mp.weixin.qq.com/s/5__o5R5SCcQf_tYFyGxEXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>住院率0%！开拓药业普克鲁胺治疗男性新冠感染III期研究成功</title>
    <updated>2021-01-07T17:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/xqVRR5afEi7U9AiWsyBiKg</id>
    <link href="https://mp.weixin.qq.com/s/xqVRR5afEi7U9AiWsyBiKg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物突破性疗法PD-1/CTLA-4双抗治疗晚期肝细胞癌适应症获批临床</title>
    <updated>2021-01-07T17:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/J4eXD-oVDo0MK4WTnfx1_Q</id>
    <link href="https://mp.weixin.qq.com/s/J4eXD-oVDo0MK4WTnfx1_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，宜昌人福药业麻醉领域再添2个通过一致性评价品种</title>
    <updated>2021-01-07T17:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/D7qyRkUtYwfB49UV44V8JA</id>
    <link href="https://mp.weixin.qq.com/s/D7qyRkUtYwfB49UV44V8JA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>40亿大品种！山东润泽「注射用头孢曲松钠」第2家通过一致性评价</title>
    <updated>2021-01-07T17:23:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/8GmFbJyYfSMUKBuELjXx9Q</id>
    <link href="https://mp.weixin.qq.com/s/8GmFbJyYfSMUKBuELjXx9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>艾伯维 risankizumab 治疗活动性银屑病关节炎 III 期研究成功</title>
    <updated>2021-01-06T18:28:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/FXs9nNIxwI6VHh9rokvaYA</id>
    <link href="https://mp.weixin.qq.com/s/FXs9nNIxwI6VHh9rokvaYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>239元/盒！GSK三联COPD新药挂网价下调73.4%</title>
    <updated>2021-01-06T18:28:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/V8qOHjSLa0zf4bvHPrUqUQ</id>
    <link href="https://mp.weixin.qq.com/s/V8qOHjSLa0zf4bvHPrUqUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​绿叶制药改良型新药「注射用利培酮缓释微球」即将获批上市</title>
    <updated>2021-01-06T18:28:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/4PZI8TNGi40n93Osu6LjUg</id>
    <link href="https://mp.weixin.qq.com/s/4PZI8TNGi40n93Osu6LjUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​阿斯利康达格列净治疗慢性肾病适应症获FDA优先审评资格</title>
    <updated>2021-01-06T18:28:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/VYEZcgPS57xDsBLYnLKkxQ</id>
    <link href="https://mp.weixin.qq.com/s/VYEZcgPS57xDsBLYnLKkxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>治疗14天，1型糖尿病风险降低59%！突破性疗法teplizumab获FDA优先审评资格</title>
    <updated>2021-01-05T18:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/snq8PzgM0UUrOB3riZWIqg</id>
    <link href="https://mp.weixin.qq.com/s/snq8PzgM0UUrOB3riZWIqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罗氏TIGIT单抗获FDA突破性疗法认定！联合阿替利珠单抗一线治疗PD- L1阳性NSCLC</title>
    <updated>2021-01-05T18:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/TrdmpxVcyYXVfkGmK4UpBQ</id>
    <link href="https://mp.weixin.qq.com/s/TrdmpxVcyYXVfkGmK4UpBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>40亿大品种！江苏奥赛康「注射用奥美拉唑钠」首家过评</title>
    <updated>2021-01-05T18:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/ViX5hXASwv22UsKSuOHzkg</id>
    <link href="https://mp.weixin.qq.com/s/ViX5hXASwv22UsKSuOHzkg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，宜昌人福药业3个麻醉品种同时通过一致性评价</title>
    <updated>2021-01-05T18:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/YtqDxFf01wg6tVi_z_dpKw</id>
    <link href="https://mp.weixin.qq.com/s/YtqDxFf01wg6tVi_z_dpKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>